These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 8370072

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Distinctive response of naïve lymphocytes from cord blood to primary activation via TCR.
    Cantó E, Rodriguez-Sanchez JL, Vidal S.
    J Leukoc Biol; 2003 Dec; 74(6):998-1007. PubMed ID: 12972509
    [Abstract] [Full Text] [Related]

  • 24. TCR-independent activation of human CD4+ 45RO- T cells by anti-CD28 plus IL-2: Induction of clonal expansion and priming for a Th2 phenotype.
    Brinkmann V, Kinzel B, Kristofic C.
    J Immunol; 1996 Jun 01; 156(11):4100-6. PubMed ID: 8666775
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Ex vivo expansion of dendritic-cell-activated antigen-specific CD4+ T cells with anti-CD3/CD28, interleukin-7, and interleukin-15: potential for adoptive T cell immunotherapy.
    Chen HW, Liao CH, Ying C, Chang CJ, Lin CM.
    Clin Immunol; 2006 Apr 01; 119(1):21-31. PubMed ID: 16406844
    [Abstract] [Full Text] [Related]

  • 30. Both naive and memory T cells can provide help for human IgE production, but with different cytokine requirements.
    van Kooten C, van der Pouw Kraan T, Rensink I, van Oers R, Aarden L.
    Eur Cytokine Netw; 1992 Apr 01; 3(3):289-97. PubMed ID: 1386757
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Differential activation of p21ras in CD45RA+ and CD45RO+ human T lymphocytes.
    Patel HR, Renz H, Terada N, Gelfand EW.
    J Immunol; 1994 Mar 15; 152(6):2830-6. PubMed ID: 8144884
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes.
    Sidorenko SP, Clark EA.
    J Immunol; 1993 Nov 01; 151(9):4614-24. PubMed ID: 8409422
    [Abstract] [Full Text] [Related]

  • 39. IL-2-resistant hyporesponsiveness induced by CD4 mAbs in OKT3-activated human T cells is reversed by CD45RA triggering.
    Robinet E, Fournel S, Fatmi A, Revillard JP.
    Cell Immunol; 1996 Jan 10; 167(1):1-7. PubMed ID: 8548832
    [Abstract] [Full Text] [Related]

  • 40. Human primary adenotonsillar naïve phenotype CD45RA CD4 T lymphocytes undergo apoptosis upon stimulation with a high concentration of CD3 antibody.
    Pajusto M, Tarkkanen J, Mattila PS.
    Scand J Immunol; 2005 Dec 10; 62(6):546-51. PubMed ID: 16316422
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.